What does the EU glucomannan cholesterol claim actually say?

A separate EU-authorized claim (distinct from the weight-loss claim) states glucomannan contributes to the maintenance of normal blood cholesterol levels, at conditions of use of 4g/day. Unlike the weight-loss claim, this one is better-supported by the trial evidence in this comparison — it is not conditional on caloric restriction the way the weight-loss claim is.

How much does glucomannan actually lower LDL cholesterol?

A meaningful, real amount. Sood 2008's meta-analysis of 14 studies (n=531) found LDL cholesterol lowered a weighted mean of 15.99 mg/dL. Chen 2003's smaller RCT (n=22, type 2 diabetics, 3.6g/day, 28 days) found a larger 20.7% drop (p=0.0004) — directionally consistent with Sood's pooled figure, though a single small trial shouldn't be treated as the headline number on its own. Neither trial suggests glucomannan replaces a statin; a 5-20% LDL drop is real and clinically relevant at population scale, but modest for any one person.

Glucomannan for Cholesterol: LDL Evidence Beats Weight-Loss Evidence

Creator: Erin Rose
Published: 2026-07-19

By Erin Rose · Updated July 19, 2026 · Methodology

Informational summary of published research and EU regulatory text — not medical advice. Talk to your doctor before changing any cholesterol treatment. This statement has not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.

Glucomannan carries a separate EU-authorized cholesterol claim (4g/day, contributes to normal blood cholesterol maintenance) — and unlike the weight-loss claim, the trial evidence behind it actually holds up. A meta-analysis of 14 studies found LDL cholesterol lowered -15.99 mg/dL (Sood 2008); a smaller RCT in type 2 diabetics found LDL fell -20.7% at 3.6g/day (Chen 2003, p=0.0004). Real and clinically meaningful at population scale — and, as with every cholesterol claim on this site, a risk-factor tool, not a statin replacement.

Two separate EU claims — don't conflate them

Glucomannan carries two distinct EU-authorized health claims, and they get confused constantly. The weight-loss claim (3g/day, three 1g doses before meals, conditional on an energy-restricted diet) is the one most marketing leans on — and it's the one the RCT evidence doesn't support (see our full breakdown). The cholesterol claim is separate: glucomannan contributes to the maintenance of normal blood cholesterol levels, at conditions of use of 4g/day — not tied to caloric restriction, and backed by more consistent trial evidence. This page is about that second claim.

The flagship evidence: Sood 2008

The broadest evidence behind glucomannan's lipid effects is Sood 2008, published in the American Journal of Clinical Nutrition: a meta-analysis of 14 studies, 531 subjects. The result: total cholesterol down a weighted mean of 19.28 mg/dL, LDL cholesterol down -15.99 mg/dL, triglycerides down 11.08 mg/dL, and fasting blood glucose down 7.44 mg/dL — but not HDL cholesterol or blood pressure, both non-significant. This is the single most-replicated lipid finding in the glucomannan evidence base, and it's the one to lead with. One honest caveat worth flagging: this same meta-analysis found a body-weight effect (−0.79 kg) that is an outlier against the two dedicated, later, and more rigorous weight-loss reviews (Keithley 2013, Onakpoya 2014) — likely reflecting an older, more heterogeneous trial pool. Trust the lipid numbers here; treat the weight number as the outlier it is.

The supporting evidence: Chen 2003

Chen 2003, a crossover RCT in the Journal of the American College of Nutrition, tested 3.6g/day of konjac glucomannan for 28 days in 22 hyperlipidemic type 2 diabetic patients. The results vs. placebo: total cholesterol −11.1% (p=0.0001), LDL cholesterol −20.7% (p=0.0004), total/HDL ratio −15.6% (p=0.0005), ApoB −12.9% (p=0.0001), fasting glucose −23.2% (p=0.002), and fecal bile-acid excretion up 75.4% (p<0.001) — the mechanism behind the lipid effect, since glucomannan binds bile acids and increases their fecal loss, forcing the liver to pull more cholesterol from circulation to make more. Triglycerides, HDL, and body weight were not significantly changed. This is the single strongest LDL number in the whole evidence base — but it's a small trial (n=22), so treat it as a supportive, mechanistically-consistent data point alongside Sood's pooled figure, not the headline on its own.

A related trial, read carefully Yoshida 2006 (n=34, with and without type 2 diabetes) tested glucomannan alongside plant sterols as well as glucomannan alone. Both the glucomannan-alone arm and the combination arm significantly lowered LDL cholesterol — but the combination-arm cholesterol figures in that trial (total cholesterol 4.72 vs 5.47 mmol/L control) reflect glucomannan plus plant sterols, not glucomannan by itself. Worth knowing the trial exists and supports glucomannan's lipid effect, but don't read its combination-arm numbers as a pure-glucomannan result.

The honest framing: risk-factor improvement, not a cure

Every number on this page measures a surrogate marker (LDL cholesterol, total cholesterol, ApoB), not a hard outcome like heart attacks or strokes. A 5–20% LDL drop, depending on which trial you weight most heavily, is a real, worthwhile risk-factor improvement — especially relevant if you're already managing elevated cholesterol or type 2 diabetes. It is not equivalent to "glucomannan prevents heart disease," and should never be read that way. If you have diagnosed high cholesterol, glucomannan is a reasonable, better-evidenced-than-its-weight-loss-claim addition to discuss with your doctor — not a substitute for your treatment plan. See psyllium's cholesterol page for the site's other fiber-cholesterol comparison — psyllium's cholesterol evidence base is larger and includes an FDA-authorized (not just EU) claim, worth reading side by side.

As an Amazon Associate we earn from qualifying purchases. Ranked by cost per gram of glucomannan, never commissions. Take with a full glass of water — see the dosage guide for the full safety rule.

Frequently asked questions

What does the EU glucomannan cholesterol claim say?

A claim separate from the weight-loss claim: glucomannan contributes to normal blood cholesterol maintenance at 4g/day, not tied to caloric restriction.

How much does glucomannan lower LDL?

Sood 2008's meta found -15.99 mg/dL across 14 studies; Chen 2003 found -20.7% at 3.6g/day in a smaller trial. Real, modest at the population level — not a statin replacement.

Is the cholesterol evidence stronger than the weight-loss evidence?

Yes — the weight-loss trials found no significant effect, while the cholesterol trials are more consistent and reproducible across an RCT and a broad meta-analysis.

Dosage Guide — full dose-by-goal breakdown, plus the water rule
Best Glucomannan Supplement — ranked by cost per gram
Does Glucomannan Cause Weight Loss? — the weaker claim, examined honestly
Psyllium for Cholesterol — the site's other fiber-cholesterol comparison
All Glucomannan Guides

Sources

Sood N, Baker WL, Coleman CI. "Effect of glucomannan on plasma lipid and glucose concentrations, body weight, and blood pressure: systematic review and meta-analysis." Am J Clin Nutr. 2008. PMID: 18842808
Chen HL, Sheu WH, Tai TS, Liaw YP, Chen YC. "Konjac supplement alleviated hypercholesterolemia and hyperglycemia in type 2 diabetic subjects — a randomized double-blind trial." J Am Coll Nutr. 2003. PMID: 12569112
Yoshida M, Vanstone CA, Parsons WD, Zawistowski J, Jones PJ. "Effect of plant sterols and glucomannan on lipids in individuals with and without type II diabetes." Eur J Clin Nutr. 2006. PMID: 16391591
EFSA NDA Panel. Health claim for glucomannan and normal blood cholesterol maintenance, authorized under EU Regulation.